Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-04-03 16:53:51 ET · period of report 2026-04-01 · accession 0000875320-26-000157 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-03 16:53 | 2026-04-01 | VRTX | Liu Joy | EVP, CLO | S - Sale | $449.17 | -978 | 21.8K | -4% | -$439.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | S | D | 978 | $449.17 | 21,833 | D | — | — | (F1) Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025. |